Increased expression of latent TGF-ß binding protein-1 and fibrillin-1 in human uterine leiomyomata

Molecular Human Reproduction

Volumn 13, Issue 5, 2007, Pages 343-349

  Zhao, Yangyu ^a,b   Wen, Yan ^a   Polan, Mary Lake ^a   Qiao, Jie ^b   Chen, Bertha H ^a  

^a STANFORD UNIVERSITY   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

17 estradiol; E2; FBN 1; Leiomyomata; LTGF 1; Myometrium

Indexed keywords

ESTRADIOL; FIBRILLIN 1; MESSENGER RNA; PROGESTERONE; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEIOMYOMA; MENSTRUAL CYCLE; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TUMOR VOLUME; UTERUS MYOMA; WESTERN BLOTTING;

ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LATENT TGF-BETA BINDING PROTEINS; LEIOMYOMA; MICROFILAMENT PROTEINS; MYOMETRIUM; PROGESTERONE; PROGESTINS; RNA, MESSENGER; UTERINE NEOPLASMS;

EID: 34447335094     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam007     Document Type: Article

References (41)

1. Andersson ML and Eggen RI (2006) Transcription of the fish Latent TGF beta-binding protein gene is controlled by estrogen receptor alpha. Toxicol In Vitro 20,417-425.
2. Berto AGA, Sampaio LO, Franco CRC, Cesar RM and Michelacci YM (2003) A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium. Biochim Biophys Acta 1619,98-112.
3. Bouzeghrane F, Reinhardt DP, Reudelhuber TL and Thibault G (2005) Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 289,H982-991.
4. Branton MH and Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1,1349-1365.
5. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F and Dietz HC (2001) Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res 88,37-43.
6. Chegini N, Ma C, Tang XM and Williams RS (2002) Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 8,1071-1078.
7. Chen B, Wen Y, Wang H and Polan ML (2003) Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol 189,59-65.
8. Chen B, Wen Y, Yu X and Polan ML (2005) Elastin metabolism in pelvic tissues: Is it modulated by reproductive hormones? Am J Obstet Gynecol 192,1605-1613.
9. Corchero J, Martin-PartidoG, Dallas SL and Fernandez-Salguero PM (2004) Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1. Int J Exp Pathol 85,295-302.
10. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS and Chegini N (1996) Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 81,3222-3230
11. Hyytiainen M, Penttinen C and Keski-Oja J (2004) Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41,233-264.
12. Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP and Sakai LY (2002) Versican interacts with fibrillin-1 and links extracellular icrofibrils to other connective tissue networks. J Biol Chem 277,4565-4572.
13. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB and Sakai LY (2003) Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278,2750-2757.
14. Kaartinen V and Warburton D (2003) Fibrillin controls TGF-beta activation. Nat Genet 33,331-332.
15. Lee Byung-Seok and Nowak R (2001) Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-B3 (TGFB3) and altered responses to the antiproliferative effects of TGFB. J Clin Endocrinol Metab 86,913-920.
16. Lorena D, Darby IA, Reinhardt DP, Sapin V, Rosenbaum J and Desmouliere A (2004) Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: Modulation by mechanical stress and role in cell adhesion. Lab Invest 84,203-212.
17. Luo X, Ding L, Xu J and Chegini N (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146,1097-1118.
18. Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T and Higashino K (1993) Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol 92,32-38.
19. Mangioni S, Vigano P, Lattuada D, Abbiati A, Vignali M and Di Blasio AM (2005) Overexpression of the Wnt5b gene in leiomyoma cells: Implications for a role of the Wnt signaling pathway in the uterine benign tumor. J Clin Endocrinol Metab 90,5349-5355.
20. Mazzieri R, Jurukovski V, Obata H, Sung J, Platt A, Annes E, Karaman-Jurukovska N, Gleizes PE and Rifkin DB (2005) Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling. J Cell Sci 118,2177-2187.
21. Mitropoulou TN and Konstantinos SD (2004) Variation in sulfation pattern of galactosaminoglycan containing proteoglycans is associated with the development of uterine leiomyoma. Biomed Chromatogr 18,411-413.
22. Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T and Nakamura H (1997) Extracellular fibrillar structure of latent TGF beta binding protein-1: Role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol 136,193-204.
23. Oklu R and Hesketh R (2000) The latent transforming growth factor beta binding protein (LTBP) family. Biochem J 352 Pt 3,601-610.
24. Perkett EA, Lyons RM, Moses HL, Brigham KL and Meyrick B (1990) Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. J Clin Invest 86,1459-1464.
25. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29, e45.
26. Saika S, MiyamotoT, TanakaT, Ishida I, Ohnishi Y and Ooshima A (2001) Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells. Br J Ophthalmol 85,1362-1366.
27. Shimomura Y, Matsuo H, Samoto T and Maruo T (1998) Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 83,2192-2198.
28. Sinha S, Heagerty AM, Shuttleworth CA and Kielty CM (2002) Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 53,971-983.
29. Son ED, Lee JY, Lee S, Kim MS, Lee BG, Chang IS and Chung JH (2005) Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating TGF-beta signaling in aged human skin in vivo. J Invest Dermatol 124,1149-1161.
30. Sozen I and Arici A (2002) Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78,1-12.
31. Taipale J, Saharinen J, Hedman K and Keski-Oja J (1996) Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44,875-889.
32. Takahashi T, Eitzman B, Bossert NL, Walmer D, Sparrow K, Flanders KC, McLachlan J and Nelson KG (1994) Transforming growth factors beta 1, beta 2, and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes. Cell Growth Differ 5,919-935.
33. Tang XM, Dou Q, Zhao Y, McLean F, Davis J and Chegini N. (1997) The expression of transforming growth factor-Bs and TGF-B receptor mRNA and protein and the effect of TGF-Bs on human myometrial smooth muscle cells in vitro. Mol Hum Reprod 3,233-240.
34. Walker CL (2002) Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma. Recent Prog Horm Res 57,277-294.
35. Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH and Funa K (1993a) Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease.AmJ Pathol 142,71-78.
36. Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin CH and Funa K (1993b) Induction of transforming growth factor-beta during cardiac allograft rejection. J Immunol 151,1147-1157.
37. Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H and Mittal K (2006) Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod 21,57-67.
38. Weikkolainen K, Keski-Oja J and Koli K (2003) Expression of latent TGF-beta binding protein LTBP-1 is hormonally regulated in normal and transformed human lung fibroblasts. Growth Factors 21,51-60.
39. Wen Y, Polan ML and Chen B (2006) Do extracellular matrix protein expressions change with cyclic reproductive hormones in pelvic connective tissue from women with stress urinary incontinence? Hum Reprod 21,1266-1273.
40. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z and Peterson HB (1994) Hysterectomy in the United States, 1988-1990. Obstet Gynecol 83,549-555.
41. Wu X, Blanck A, Norstedt G, Sahlin L and Flores-Morales A (2002) Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium. Mol Hum Reprod 8,246-254.